Codex @codex  0

Chest discomfort associated with transient inadequate oxygen supply to the myocardium relative to its requirements. Several mechanisms can produce the syndrome.

Atrial contraction is active shortening of the atrial myocardium that contributes to moving blood from the atria into the ventricles. In the usual coordinated cardiac cycle, it occurs late in ventricular diastole, while the mitral valve and tricuspid valve permit filling. It supplements earlier passive filling; ventricular filling is not restricted to the period of atrial contraction.^[ref]

For the left atrium, this active contribution is called atrial booster-pump function, distinguishable from atrial reservoir function and atrial conduit function. A volume balance separates storage from transport:where $Q_{\mathrm{PV}}$ is summed pulmonary vein inflow and $Q_{\mathrm{mitral}}$ is net outflow through the mitral valve. During atrial contraction, a decrease in chamber volume can accompany outflow larger than the continuing inflow.

In an original example, the left atrium loses 15 mL during a chosen contraction interval while receiving 5 mL through the pulmonary veins. Integrating the balance shows that 20 mL must have left through the mitral valve. The volume decrease alone would undercount that interval's forward transport by 5 mL. Conversely, not all blood entering the left ventricle in that interval was necessarily stored before contraction began.

The distinction matters experimentally: a changing cavity volume, a velocity recorded at a valve and the trajectory of a particular parcel of blood are different observations. A primary flow-component study used time-resolved computed tomography, computational fluid dynamics and modeled particle paths to distinguish atrial transport routes.^[ref] A volume change associated with contraction is informative, but its interpretation requires the concurrent inflows and outflows.

The region connecting atrial and ventricular compartments during cardiac development. Its regulatory programme differs from that of rapidly expanding chamber myocardium.

Inflammation affecting tissue of the heart. The term is broad: specifying endocardium, myocardium or pericardium identifies anatomically different processes that can have different consequences.

C. E. Nerantzis is an author of anatomical research on coronary arteries and their distribution in the human heart. The 1996 primary paper Functional dominance of the right coronary artery: incidence in the human heart by C. E. Nerantzis and others lists the author with the Pathology Department, University of Athens. Its byline establishes the initials used here; it does not by itself establish a fuller personal name.^[ref]

Nerantzis and colleagues studied 200 human hearts after injection of radiopaque material, combining direct observation with X-ray analysis. They classified 178 as right dominant because the right coronary artery gave rise to the posterior interventricular artery. Within those 178, they distinguished 19 specimens with both a large posterior branch and a large continuation beyond the crux. The mapped right coronary artery in this subgroup supplied the right ventricle and nearly half the left ventricle.^[ref]

The nested counts show why a classification and a detailed territory map are different observations: $178/200=89\%$ of this collection met the usual right-dominance criterion, but the described extended subgroup was $19/178\approx 10.7\%$ of those right-dominant hearts. These sample fractions do not automatically estimate every population. The work illustrates how coronary dominance summarizes a branch origin while leaving additional variation in arterial extent.

Radiopaque filling makes the vessel paths visible; it does not directly measure living blood flow under exercise or after an obstruction. The anatomical observation motivates questions about which myocardium a proximal lesion could affect, while physiological flow and clinical outcome require additional evidence.

myocardium acquiring chamber-associated growth, structural and electrophysiological properties, distinct from specialized non-chamber territories.

Coronary angiography images the coronary arteries using a contrast medium and X-rays. In conventional invasive coronary angiography, a catheter delivers contrast to the coronary circulation while the imaging system records the contrast-filled vessel paths. The contrast improves visibility of the blood-filled lumen against surrounding tissue.^[ref]

The apparatus connects fluid delivery to imaging geometry. An X-ray source and detector record the contrast signal during its passage through the vessels; changing viewing angle changes how overlapping arterial segments project into the image. The result is primarily a description of the contrast-filled lumen. It is not a direct measurement of every feature of the arterial wall or of how much oxygen reaches the myocardium.

An original geometric example shows why one apparent width can be incomplete evidence. Suppose a local lumen has an elliptical area with diameters $3.0$ and $1.5\mathrm{mm}$. Its area ishalf that of a circular $3.0\mathrm{mm}$ lumen. One viewing direction can nevertheless show the same $3.0\mathrm{mm}$ projected width as that circle, while an orthogonal view shows $1.5\mathrm{mm}$. A projected width does not uniquely determine lumen area without a shape and viewing model. These chosen dimensions are not a diagnostic threshold.

Timing and motion matter too: a moving vessel and changing contrast concentration can alter the recorded signal. A geometric narrowing, a pressure difference and downstream blood delivery are related observations but are not interchangeable. A physiological assessment needs evidence beyond one static projection.

Coronary CT angiography uses a different acquisition geometry: many X-ray views are reconstructed into a volume, commonly after contrast administration through a peripheral vein. The NHLBI account distinguishes cardiac computed tomography from the catheter-based angiographic description.^[ref] Naming the method makes clear whether a claim concerns a projection sequence or a reconstructed three-dimensional image.

A coronary artery is an artery supplying the heart's own tissues, especially the myocardium. The main left coronary artery and right coronary artery arise from the proximal aorta near the aortic valve. Their branches supply the working cardiac muscle rather than merely conveying blood through the heart's chambers.^[ref]

This arrangement separates two circulations that can otherwise be confused. Blood inside a cardiac chamber is being pumped onward; coronary blood flow brings oxygen and other materials to the living wall doing the pumping. An open chamber and a patent large coronary artery therefore answer different anatomical questions. Distribution through smaller vessels and exchange with tissue also matter.

An original conservation calculation illustrates the supply problem. If coronary volume flow is $Q$ and arterial oxygen content is $C_a$, then coronary oxygen delivery isWith chosen values $Q=250\mathrm{mL}\mathrm{mi}{\mathrm{n}}^{-1}$ and $C_a=0.20\mathrm{mL}{\mathrm{O}}_2\mathrm{m}{\mathrm{L}}^{-1}$, delivery is $50\mathrm{mL}{\mathrm{O}}_2\mathrm{mi}{\mathrm{n}}^{-1}$. If a representative venous oxygen content is $C_v=0.08\mathrm{mL}{\mathrm{O}}_2\mathrm{m}{\mathrm{L}}^{-1}$, a steady-state inflow–outflow balance givesHere $E$ is the coronary oxygen extraction fraction. The example assumes matched inflow and outflow from the same represented tissue, with negligible oxygen accumulation; these are illustrative values, not clinical reference limits. Delivery and extraction distinguish a flow measurement from the tissue's oxygen use.

Vascular stenosis can change the supply route, while the observed consequence depends on more than one geometric percentage. Coronary angioplasty targets a narrowed arterial segment. The historical primary study measured both stenosis and the pressure difference across the affected region, making anatomy and a physiological observation available together.^[ref] Neither observation by itself supplies all the information in the oxygen balance above.

The coronary circulation supplies and drains the heart's own tissue. Coronary arteries branch from the aorta to supply the myocardium; cardiac veins return blood toward the right atrium.^[ref] Blood moving through a ventricular cavity is not the same flow as blood perfusing the surrounding muscle.

Much coronary venous return passes through the coronary sinus, while anterior cardiac veins provide a direct route to the right atrium.^[ref] Consequently a coronary-sinus sample represents its drainage territory rather than automatically every part of the heart. Anatomical pathways must match the region whose blood flow and oxygen uptake are being estimated.

An original tissue-balance example uses regional flow $Q=80\mathrm{mL}\mathrm{mi}{\mathrm{n}}^{-1}$, arterial oxygen content $C_a=0.20\mathrm{mL}{\mathrm{O}}_2\mathrm{m}{\mathrm{L}}^{-1}$ and matching venous oxygen content $C_v=0.08$ in the same units. Then regional coronary oxygen uptake isThe arterial delivery rate is $Q{C}_a=16$ in those units. Delivery and uptake differ because oxygen remains in the returning blood. The values are stipulated, not normal-reference limits.

A primary 2007 experiment measured coronary volumetric flow using continuous saline thermodilution, an infusion catheter and a pressure/temperature guidewire, with comparisons in dogs and patients.^[ref] This provides a concrete way to investigate the flow term; it does not by itself measure the oxygen-content difference.

The arterial map also varies among hearts. A radiopaque-injection study classified 178 of 200 examined hearts as right dominant by the origin of the posterior interventricular artery.^[ref] Dominance names an anatomical branching criterion, not a claim that one artery supplies the entire heart.

The inner endothelial lining of the heart, which also provides developmental signals to neighbouring myocardium.

An early cardiac progenitor domain that differentiates into much of the initial myocardium, with major contributions to the left ventricle in mouse. Its boundaries and contributions require stage- and species-specific fate mapping.

Increased mass of the left ventricular myocardium. Pressure load, volume load and other influences can produce different patterns, connecting a structural change with the stimulus that drives remodeling.

Inadequate oxygen delivery to the myocardium relative to its metabolic requirements.

A suitable published comparison is J. B. Junor's 1858 report of cardiac rupture with a soft, fatty ventricular wall and blood in the pericardium. The comparison comes from the published clinical record.

The patient was a woman of about seventy with repeated vomiting and an initially weak pulse. She deteriorated after a severe episode of vomiting, her radial pulse becoming almost imperceptible, and died a few hours later. At examination after death, a large gallstone was found impacted in the ileum. The pericardium contained much blood. The small, atrophied heart had an extremely soft and fatty right cardiac ventricle; when it was raised, blood emerged through several small fissures, and its tissue broke under very gentle handling. ^[ref]

The comparison is anatomical and pathological: a fragile ventricular wall, escape of blood and death. There are also important differences. Morgagni's tear is in the left cardiac ventricle; J. B. Junor's reported fissures concern the right cardiac ventricle and were described during handling of a very friable heart. The latter account includes intestinal obstruction and does not reproduce Morgagni's sternal and arm pain. It supports the possibility of severe muscular degeneration in a ruptured heart, without establishing that the two patients had identical disease or that every observed fissure opened before death.

Probable muscular condition in an 1864 answer. The fibres around the tear were probably structurally weakened and softened; fatty degeneration of the heart is a strong historical pathological suggestion. This means alteration within damaged muscular fibres, rather than merely an abundance of adipose tissue outside them. In Richard Quain's account, reproduced before the examination, microscopic fatty change involved loss of the normal transverse markings and refractile fatty particles within the fibre sheath. Extensive change could accompany a pale, mottled, flabby myocardium. Those are findings one would look for, not observations supplied by the Oxford passage. ^[ref]

An appropriate investigation would compare thin preparations from the tear's margin with apparently unaffected myocardium under a microscope, looking at the cross-striation, continuity of the muscular structure and position of the fatty particles. Fat lying between bundles is different from particles lying within damaged fibres. The gross appearance, the microscopic preparation and the sampling site must be reported separately. The word “erosion” does not by itself supply these microscopic findings. ^[ref]

Modern interpretation and its limit. Rupture of a left ventricular free wall can follow myocardial infarction, where a zone of damaged myocardium becomes friable. That is a plausible modern differential for the combination of chest and arm pain, weak pulse and a tear, but the historical record does not supply coronary anatomy or histology sufficient to prove it. A sudden collection of blood in the pericardium, or haemopericardium, can impair cardiac filling and cause cardiac tamponade. This provides a mechanism compatible with the abrupt pallor and collapse; pericardial pressure was not measured in the reported case. Present-day assessment could use urgent echocardiography; that technology belongs to the later comparison. ^[ref]

The defensible conclusion is a ruptured, locally weakened myocardium, with fatty degeneration of the heart a probable nineteenth-century interpretation and infarct-related damage a modern possibility requiring additional evidence.

Angina pectoris is most usefully explained by transient inadequacy of the myocardial oxygen supply relative to demand. It is a clinical syndrome, rather than the name of one visible anatomical lesion. The characteristic constricting chest discomfort may radiate to the arm, neck or jaw and be provoked by effort; the question concerns its causes, not a claim that every chest pain is angina pectoris.^[ref]

The common structural basis is coronary atherosclerosis. Narrowing limits the increase of coronary blood flow that should accompany exercise. An affected heart may receive sufficient oxygen at rest and insufficient oxygen when its rate, force of contraction and wall stress rise. Plaque disruption with thrombosis can abruptly worsen supply; persistent severe ischemia can then cause myocardial infarction. Pain from transient ischemia does not by itself prove myocardial necrosis.

Other mechanisms include coronary artery spasm, impaired regulation of small coronary vessels, or increased demand in left ventricular hypertrophy, severe aortic stenosis, or tachycardia. Reduced delivery through severe anaemia, low arterial oxygen or low perfusion pressure may provoke symptoms even without a new obstructing plaque. Structural narrowing, vasomotor change, blood oxygen-carrying capacity and cardiac work therefore have to be considered together.^[ref]

For an 1865 interpretation, coronary “ossification” or degeneration, diseased cardiac or aortic structures and neural or spasmodic explanations belonged to the historical discussion. These did not establish a single universal cause. A report published in January 1865 described a pathological case associated angina pectoris with diseased coronary arteries, but isolated cases cannot demonstrate that a particular valve or vessel lesion is necessary in every patient.^[ref] The modern supply-and-demand account explains why severe symptoms can coexist with relatively inconspicuous large coronary arteries, and why substantial coronary disease need not cause pain at every moment.

A pathological investigation inspects the coronary origins and course, their lumen and wall, the myocardium, the aortic valve and ventricular thickness. Clinical investigation adds evidence of reversible myocardial ischaemia and distinguishes it from infarction or non-cardiac pain. Modern electrocardiography and appropriate imaging address functions that a nineteenth-century post-mortem inspection alone could not measure. A normal-looking vessel on gross inspection cannot exclude coronary microvascular disease or a transient coronary artery spasm.

The looping heart tube emerges through staged recruitment and differentiation of regionally distinct progenitors. Developmental time changes a cell's competence and signalling environment, while anatomical position determines its neighbours, migration route and eventual contribution. The tube is therefore not produced by simultaneous differentiation of a homogeneous cardiac population, and chronological age alone does not specify a cell's developmental state.

The process begins before a recognizable heart exists. During gastrulation, cardiogenic mesoderm emerges from the primitive streak and moves into an anterior lateral environment, where interactions with neighbouring tissues help establish cardiac competence. Timed clonal labelling of Mesp1-expressing progenitors showed that populations labelled at different gastrulation times make different regional and lineage contributions to the mouse heart. ^[ref] This supports early regional segregation and restriction, rather than a single unrestricted precursor pool mixing uniformly until the heart tube forms. It does not mean that a pulse of marker expression is itself a complete autonomous clock: labelling time also selects cells at different positions and under different signalling conditions.

In mouse, the first heart field differentiates relatively early within the cardiac crescent and contributes substantially to initial myocardium, including much of the future left ventricle. Folding and convergence bring myocardial and endocardial components into the forming heart tube. Other cardiac progenitors remain outside the initial differentiated structure. Thus the location of a progenitor at one stage need not equal its later location in the organ; fate maps must follow tissue movement as well as the onset of a marker.

The second heart field maintains a proliferative reservoir that supplies additional cells as the tube elongates and loops. Contributions are made at the arterial pole of the heart and the venous pole of the heart, with different subregions supplying outflow, right-ventricular, atrial and inflow territories in the mouse. ISL1-associated lineage tracing and mutant analysis established major contributions from a population that proliferates before differentiating. ^[ref] ISL1 expression is consequently useful in the context of a dynamic lineage; it is not a permanent marker of one mature myocardial subtype. Species, timing and driver history must be specified when assigning exact heart-field boundaries.

Retention of progenitors outside the tube and their differentiation on entry solve different developmental tasks. If too many differentiate too early, the reservoir may be depleted before the organ receives enough cells; if they remain undifferentiated too long, the growing tube may lack functional myocardium. A small outflow region can therefore result from reduced specification, insufficient progenitor proliferation, failed migration, premature differentiation or poor survival. Counting cells only in the final tube cannot distinguish these explanations.

Signal timing supplies a direct reason for such context dependence. Experiments in zebrafish and embryonic stem-cell differentiation showed biphasic effects of Wnt signalling: activity at earlier and later stages had different consequences for cardiac specification. ^[ref] This does not imply that Wnt must always be completely absent from every later cardiac progenitor, because maintenance of specific progenitor domains has additional signalling requirements. Rather, the same pathway acts on different regulatory states as development proceeds. A timed activation or inhibition experiment must therefore define the precursor state and assay actual differentiated output instead of treating pathway activity as a timeless instruction to form heart.

Feedback also coordinates specification and expansion. In mouse, NKX2-5-dependent restraint of Bmp2/Smad1 signalling regulates the transition between early cardiac specification, second-heart-field proliferation and outflow development. Mutants showed increased specification-associated and progenitor programmes initially but later failed to sustain normal expansion; reducing Smad1 activity rescued important aspects of the phenotype. ^[ref] This is a particularly informative genetic interaction because it shows that stronger expression of an induction programme need not yield more successfully deployed differentiated myocardium. Pathway dose, time and location jointly determine the outcome.

Direct timing measurements show that addition to the tube can continue through new differentiation rather than division of existing cardiomyocytes alone. In zebrafish, fluorescent reporter maturation and photoconversion distinguished earlier differentiated cells from later contributions, identifying distinct phases and late addition at the arterial pole. ^[ref] photoconversion acts as a time stamp: a cell that first differentiates after conversion can carry a different reporter history from one already in the tube. Controls for incomplete conversion, fluorophore maturation, dilution and imaging damage are essential. Measuring cell cycle activity in parallel separates differentiation of recruited cells from proliferation of cells already present.

Position within the forming organ further shapes what differentiation means. myocardium, endocardium and supporting mesenchyme have different programmes and communicate across their interfaces. Along the tube, prospective chamber regions acquire different growth and functional properties from connecting or outflow territories; a generic cardiomyocyte marker does not establish chamber-specific maturation. The atrioventricular canal, for example, is not simply a less advanced sample of every future chamber cell. Regional differences can be actively maintained while the whole organ continues developing.

The left–right axis adds another positional dimension. Asymmetric PITX2-associated programmes link embryonic sidedness to organ morphogenesis, including heart looping. ^[ref] However, looping direction and myocardial differentiation are separable readouts. Reversed or abnormal geometry does not automatically imply failure to acquire cardiac identity, while a normally oriented but undersized tube can still contain an important differentiation defect. Three-dimensional imaging of sidedness, tube shape and regional markers is therefore needed to relate position to cell state rather than inferring one from the other.

An effective experimental design combines timed lineage induction, live-cell imaging and spatial molecular measurements. Compare matched morphological stages or somite counts as well as elapsed time, since a perturbation can delay the entire embryo. Apply pathway manipulations before and after progenitor specification, and measure proliferation, apoptosis, migration, cell entry and sarcomeric differentiation separately. A pulse-labelled lineage reveals descendants, whereas marker expression in a snapshot reveals current state; single-cell trajectories alone do not demonstrate ancestry. Tissue-restricted rescue can test whether a phenotype originates within a cardiac progenitor or in its signalling environment.

Finally, the onset of contraction and blood flow introduces new mechanical and physiological conditions during morphogenesis, but these should not be used to erase earlier temporal differences. A marker of contractile machinery, organized sarcomeres, beating, chamber-specific electrophysiology and adult-like maturation are progressively different endpoints. The relevant endpoint for emergence of the looping tube is appropriately timed regional deployment of differentiated cells, not completion of every mature cardiac property.

Time establishes competence and the sequence of recruitment; location supplies distinct signals, constraints and lineage destinations. Their interaction permits an early working tube to coexist with later progenitor addition and progressive regional specialization, and explains why the same molecular perturbation can have different effects at different stages or poles.

A population of cardiac progenitors that contributes cells to the developing heart after initial heart-tube formation. Retaining a proliferative reservoir allows progressive addition of differentiated myocardium.

Volume normalization of ventricular pressure-volume curves expresses chamber volume relative to a stated reference scale before comparing pressure-volume relations. It can separate the effect of chamber size from differences in the shape of an end-diastolic pressure-volume relationship. It does not automatically remove effects of wall thickness, geometry, external pressure or active state.

Let $v=V/V_s$ for fixed positive reference volume $V_s$, and suppose $p=F(v)$. The chain rule givesThus equal normalized curves can have different dimensional ventricular compliances. The scaled compliance $C_V/V_s=1/F^{\prime }(v)$ has units of inverse pressure and compares the same normalized operating point.

For an original example, take $F(v)=2[e^{3(v-1)}-1]$ mmHg. At $v=1.2$, pressure is 1.644 mmHg and $F^{\prime }(v)=6e^{0.6}\simeq 10.933$ mmHg. Chambers with $V_s=100$ and 200 mL then have volumes 120 and 240 mL and compliances approximately 9.147 and 18.294 mL/mmHg. Their compliances differ by twofold while $C_V/V_s\simeq 0.09147\mathrm{mmH}{\mathrm{g}}^{-1}$ agrees. These are chosen model chambers, not reference values.

An affine convention $v=(V-V_r)/V_s$ must state both its origin $V_r$ and scale $V_s$. Choosing each curve's reference from the same data can also conceal the very shift being compared. Normalizing every single observation by its own volume makes every normalized volume one and destroys information about curve shape.

An experimental comparison needs independent volume information and a specified pressure reference. The 1994 isolated-heart study used known intraventricular balloon volumes, micromanometer pressure and image-derived ventricular area to compare pressure-volume and pressure-area measurements.^[ref] That apparatus illustrates why a geometric surrogate must be checked before it becomes the denominator of a normalization.

A transparent report identifies the reference volume, whether pressure is intracavity or transmural pressure, the cardiac phase and the operating points compared. A size-normalized chamber curve is still a chamber measurement; it is not by itself a material stress-strain relation for myocardium.